scispace - formally typeset
P

Péter Klivényi

Researcher at University of Szeged

Publications -  218
Citations -  8770

Péter Klivényi is an academic researcher from University of Szeged. The author has contributed to research in topics: Medicine & Neuroprotection. The author has an hindex of 39, co-authored 187 publications receiving 8074 citations. Previous affiliations of Péter Klivényi include Cornell University & Harvard University.

Papers
More filters
Journal ArticleDOI

Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine

TL;DR: The present results indicate that a knock-out of GSHPx may be adequately compensated under nonstressed conditions, but that after administration of mitochondrial toxins GSHpx plays an important role in detoxifying increases in oxygen radicals.
Journal ArticleDOI

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis

TL;DR: It was found that oral administration of creatine produced a dose-dependent improvement in motor performance and extended survival in G93A transgenic mice, and it protected mice from loss of both motor neurons and substantia nigra neurons at 120 days of age.
Journal ArticleDOI

Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice.

TL;DR: A set of coculture conditions is provided that allows rapid and efficient derivation of most central nervous system phenotypes and transplantation of ES and ntES cell–derived dopaminergic neurons corrected the phenotype of a mouse model of Parkinson disease, demonstrating an in vivo application of therapeutic cloning in neural disease.
Journal ArticleDOI

Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease

TL;DR: Results show that administration of phenylbutyrate, at doses that are well tolerated in man, exerts significant neuroprotective effects in a transgenic mouse model of HD, and therefore represents a very promising therapeutic approach for HD.
Journal ArticleDOI

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

Niklas Mattsson, +77 more
TL;DR: The cerebrospinal fluid biomarkers amyloid β (Aβ)‐42, total‐Tau (T‐tau), and phosphorylated‐t Tau (P‐tAU) demonstrate good diagnostic accuracy for Alzheimer's disease (AD), but there are large variations in biomarker measurements between studies, and between and within laboratories.